カテゴリ： MarketLine, イギリス, 企業調査

Vectura Group plc：企業の戦略・SWOT・財務情報

◆英語タイトル：Vectura Group plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1951
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：48
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Vectura Group plc – Strategy, SWOT and Corporate Finance Report
Summary

Vectura Group plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vectura Group plc (Vectura or ‘the group’) is engaged in the development of pharmaceutical therapies for the treatment of airways-related diseases. It develops inhalation products to diseases such as obstructive pulmonary disease (COPD), cystic fibrosis, asthma, chronic pulmonary fibrosis and other diseases. It offers dry powder inhalers (DPIs), pressurized metered dose inhaler (pMDI) and smart nebulizer delivery systems. The group’s portfolio is comprised of partnered and licensed marketed products as well as branded and generic investigational drugs. The group operates in the US, the UK and other European countries. It is headquartered in Wiltshire, UK.

Scope

- Detailed information on Vectura Group plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vectura Group plc in the form of a SWOT analysis
- An in-depth view of the business model of Vectura Group plc including a breakdown and examination of key business segments
- Intelligence on Vectura Group plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vectura Group plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vectura Group plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vectura Group plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vectura Group plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Vectura Group plc: Company Overview 9
Vectura Group plc: Overview and Key Facts 9
Vectura Group plc: Overview 9
Vectura Group plc: Key Facts 9
Vectura Group plc: Key Employees 10
Vectura Group plc: Key Employee Biographies 11
Vectura Group plc: Major Products and Services 15
Vectura Group plc: Company History 17
Vectura Group plc: Management Statement 21
Vectura Group plc: Locations and Subsidiaries 24
Vectura Group plc: Key Competitors 25
Vectura Group plc: Company Analysis 26
Vectura Group plc: Business Description 26
Vectura Group plc: SWOT Analysis 27
Vectura Group plc: SWOT Overview 27
Vectura Group plc: Strengths 27
Vectura Group plc: Weaknesses 28
Vectura Group plc: Opportunities 28
Vectura Group plc: Threats 29
Vectura Group plc: Corporate Financial Deals Activity 30
Vectura Group plc: Financial Deals Overview 30
Vectura Group plc: Targets and Partners 32
Vectura Group plc: Top Deals 2014 – 2018YTD* 33
Vectura Group plc: Advisors 34
Vectura Group plc: Top Legal Advisors 34
Vectura Group plc: Top Financial Advisors 34
Vectura Group plc: Mergers and Acquisitions 35
Vectura Group plc: Capital Raising 36
Vectura Group plc: Partnership 37
Vectura Group plc: Recent Developments 38
Vectura Group plc: News and Events Summary 38
Vectura Group plc: Business Expansion 41
Vectura Group plc: Corporate Governance 41
Vectura Group plc: Financial Deals 42
Vectura Group plc: Financial Performance 42
Vectura Group plc: Market Developments 43
Vectura Group plc: Research & Development 44
Vectura Group plc: Strategy and Operations 45
Appendix 46
Contact Us 46
Methodology 46
About MarketLine 47

List of Tables
Table 1: Vectura Group plc: Key Facts
Table 2: Vectura Group plc: Key Employees
Table 3: Vectura Group plc: Locations and Subsidiaries
Table 4: Vectura Group plc: Key Competitors
Table 5: Vectura Group plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vectura Group plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Vectura Group plc: M&A Average Deal Size - Value (US$m)
Table 8: Vectura Group plc: Targets and Partners
Table 9: Vectura Group plc: Top Deals 2014 - 2018YTD*
Table 10: Vectura Group plc: Legal Advisor Ranking by Value (US$m)
Table 11: Vectura Group plc: Financial Advisor Ranking by Value (US$m)
Table 12: Vectura Group plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Vectura Group plc: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Vectura Group plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Vectura Group plc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Vectura Group plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Vectura Group plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Vectura Group plc: News and Events Summary
Table 19: Vectura Group plc: Business Expansion
Table 20: Vectura Group plc: Corporate Governance
Table 21: Vectura Group plc: Financial Deals
Table 22: Vectura Group plc: Financial Performance
Table 23: Vectura Group plc: Market Developments
Table 24: Vectura Group plc: Research & Development
Table 25: Vectura Group plc: Strategy and Operations

List of Figures
Figure 1: Vectura Group plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vectura Group plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Vectura Group plc: M&A Average Deal Size - Value (US$m)
Figure 4: Vectura Group plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Vectura Group plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Vectura Group plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Vectura Group plc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Vectura Group plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Vectura Group plc: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Vectura Group plc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • BioCryst Pharmaceuticals Inc (BCRX)：企業の財務・戦略的SWOT分析
    BioCryst Pharmaceuticals Inc (BCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • MediGene AG (MDG1)：製薬・医療：M&Aディール及び事業提携情報
    Summary MediGene AG (MediGene) is a biotechnology company which develops drugs for the treatment of various types and stages of cancer with candidates in clinical and pre-clinical development. The company focuses on the development of personalized T-cell-based immunotherapies. Its core business deve …
  • Camurus AB (CAMX)：企業の財務・戦略的SWOT分析
    Summary Camurus AB (Camurus), a subsidiary of Sandberg Development AB, is a pharmaceutical company that carries out development and commercialization of treatments for the patients suffering from chronic diseases. The company’s technology includes smart and versatile drug delivery, injection depot, …
  • Takuma Co Ltd (6013)：企業の財務・戦略的SWOT分析
    Takuma Co Ltd (6013) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hays plc：企業の戦略・SWOT・財務分析
    Hays plc - Strategy, SWOT and Corporate Finance Report Summary Hays plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Verisante Technology Inc：企業の戦略的SWOT分析
    Verisante Technology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Belfius Bank SA：企業の戦略・SWOT・財務情報
    Belfius Bank SA - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • AccentCare Inc：企業の戦略的SWOT分析
    AccentCare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • ProMIS Neurosciences Inc (PMN)：医療機器：M&Aディール及び事業提携情報
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, helps in pred …
  • NEX Group plc. (IAP)：企業の戦略的SWOT分析
    NEX Group plc. (IAP) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Kuwait Food Company (Americana) KSCP：企業の戦略的SWOT分析
    Kuwait Food Company (Americana) KSCP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • BKW AG：企業の戦略・SWOT・財務分析
    BKW AG - Strategy, SWOT and Corporate Finance Report Summary BKW AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Vestas Wind Systems AS (VWS)-エネルギー分野：企業M&A・提携分析
    Summary Vestas Wind Systems A/S (Vestas) is a renewable energy company that designs, manufactures, constructs, installs, and services wind turbines. The company partners with customers to monitor wind energy production and performance of the wind power plant throughout its lifetime. It offers soluti …
  • High Peak Royalties Limited (HPR)：企業の財務・戦略的SWOT分析
    High Peak Royalties Limited (HPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Petroleos de Venezuela SA-エネルギー分野：企業M&A・提携分析
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …
  • National Savings and Investments (NS&I)：企業の戦略・SWOT・財務情報
    National Savings and Investments (NS&I) - Strategy, SWOT and Corporate Finance Report Summary National Savings and Investments (NS&I) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Republic Bancorp, Inc.：企業の戦略・SWOT・財務情報
    Republic Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report Summary Republic Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Immunomedics Inc (IMMU)：医療機器：M&Aディール及び事業提携情報
    Summary Immunomedics Inc (Immunomedics) is a clinical-stage bio-pharmaceutical company that researches, develops, manufactures and commercializes monoclonal antibody-based drugs for the treatment of cancer and autoimmune disorders. The company develops its candidates based on its proprietary technol …
  • Nine Entertainment Co. Holdings Ltd：企業の戦略・SWOT・財務分析
    Nine Entertainment Co. Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Entertainment Co. Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Coutts & Co.：企業の戦略・SWOT・財務情報
    Coutts & Co. - Strategy, SWOT and Corporate Finance Report Summary Coutts & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆